Apomax Limited 31/12/2020 iXBRL

0 31/12/2020 2020-12-31 false false false false false false false false false false true false false true false false false false false false false No description of principal activities is disclosed 2020-01-01 Sage Accounts Production 2020 Update 1 - FRS102_2019 xbrli:pure xbrli:shares iso4217:GBP 08800832 2020-01-01 2020-12-31 08800832 2020-12-31 08800832 2019-12-31 08800832 bus:RegisteredOffice 2020-01-01 2020-12-31 08800832 bus:LeadAgentIfApplicable 2020-01-01 2020-12-31 08800832 bus:Director1 2020-01-01 2020-12-31 08800832 bus:Director2 2020-01-01 2020-12-31 08800832 bus:Director3 2020-01-01 2020-12-31 08800832 core:WithinOneYear 2020-12-31 08800832 core:WithinOneYear 2019-12-31 08800832 core:AfterOneYear 2020-12-31 08800832 core:AfterOneYear 2019-12-31 08800832 bus:Director3 2019-12-31 08800832 bus:Director3 2020-12-31 08800832 bus:Director3 2018-12-31 08800832 bus:Director3 2019-12-31 08800832 bus:Director3 2019-01-01 2019-12-31 08800832 bus:Micro-entities 2020-01-01 2020-12-31 08800832 bus:AuditExemptWithAccountantsReport 2020-01-01 2020-12-31 08800832 bus:FullAccounts 2020-01-01 2020-12-31 08800832 bus:SmallCompaniesRegimeForAccounts 2020-01-01 2020-12-31 08800832 bus:PrivateLimitedCompanyLtd 2020-01-01 2020-12-31

Company registration number: 08800832

Apomax Limited

Unaudited filleted financial statements

31 December 2020

Apomax Limited

Contents

Directors and other information

Accountants report

Statement of financial position and notes to the financial statements

Apomax Limited

Directors and other information


	Directors	Mr Stelios Anastasiou
		Mr Emilios Nicolaou
		Mr Pantelis Tsiranidis


	Company number	08800832


	Registered office	30-40 Eastcheap
		City of London
		London
		EC2M 3TY


	Business address	Vision Tower Floors 4th & 5th
		67 Limassol Avenue
		Aglantzia
		Nicosia Cyprus
		2121


	Accountants	Kay Peters & Co
		Ground Floor East
		30-40 Eastcheap
		City of London
		London
		EC3M 1HD




	Bankers	Credit Suisse AG
		CH-0870
		Zurich (0835)
		Switzerland

Apomax Limited

Report to the board of directors on the preparation of the

unaudited statutory financial statements of Apomax Limited

Year ended 31 December 2020

In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the financial statements of Apomax Limited for the year ended 31 December 2020 which comprise the statement of financial position and related notes from the company's accounting records and from information and explanations you have given us.

As a practising member firm of the Association of Chartered Certified Accountants , we are subject to its ethical and other professional requirements which are detailed at http://www.accaglobal.com/en/member/ professional-standards/ rules-standards/acca-rulebook.html.

This report is made solely to the board of directors of Apomax Limited, as a body, in accordance with the terms of our engagement letter. Our work has been undertaken solely to prepare for your approval the financial statements of Apomax Limited and state those matters that we have agreed to state to the board of directors of Apomax Limited as a body, in this report in accordance with the requirements of the Association of Chartered Certified Accountants as detailed at http://www.accaglobal.com/content/dam/ACCA_Global /Technical/fact/technical-factsheet-163.pdf. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than Apomax Limited and its board of directors as a body for our work or for this report.

It is your duty to ensure that Apomax Limited has kept adequate accounting records and to prepare statutory financial statements that give a true and fair view of the assets, liabilities, financial position and loss of Apomax Limited. You consider that Apomax Limited is exempt from the statutory audit requirement for the year.

We have not been instructed to carry out an audit or a review of the financial statements of Apomax Limited. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory financial statements.

We have relied on the figures provided by the accountants acting for the company's overseas branch which accounts for all the transactions on these financial statements.

Kay Peters & Co

Chartered Certified Accountants

Ground Floor East

30-40 Eastcheap

City of London

London

EC3M 1HD

24 September 2021

Apomax Limited

Statement of financial position

31 December 2020

	2020		2019
	£	£	£	£

Current assets	1,075,456		1,082,259
Prepayments and accrued income	19,646		19,471
	_______		_______
		1,095,102		1,101,730

Creditors: amounts falling due within one year		( 81)		( 57)
		_______		_______

Net current assets		1,095,021		1,101,673
		_______		_______

Total assets less current liabilities		1,095,021		1,101,673

Creditors: amounts falling due after more than one year		( 1,064,862)		( 1,054,374)

Accruals and deferred income		-		( 2,644)

		_______		_______
Net assets		30,159		44,655
		_______		_______

Capital and reserves		30,159		44,655
		_______		_______

Notes to the financial statements

Apomax Limited

Year ended 31 December 2020

1. Employee numbers

The average number of persons employed by the company during the year amounted to Nil (2019: Nil).

2. Directors advances, credits and guarantees

	During the year the directors entered into the following advances and credits with the company:

2020
		Balance brought forward	Advances /(credits) to the directors	Amounts repaid	Balance o/standing
		£	£	£	£
	Mr Pantelis Tsiranidis	( 1,054,374)	( 10,488)	-	( 1,064,862)
		_______	_______	_______	_______

2019
		Balance brought forward	Advances /(credits) to the directors	Amounts repaid	Balance o/standing
		£	£	£	£
	Mr Pantelis Tsiranidis	( 1,106,583)	-	52,209	( 1,054,374)
		_______	_______	_______	_______

The director's loan is unsecured, it is not subject to interest and no date of repayment has been set. The directors retain the right to charge interest and set the repayment date which will be dependent on the company's performance.

3. Overseas branch

The amounts in the financial statements have been solely generated by the company's overseas branch.

4. Going Concern

The company is dependent on its director and major shareholder for financial support to continue as a going concern.

For the year ending 31 December 2020 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors responsiblities:

- The member has not required the company to obtain an audit of its accounts for the year in question in accordance with section 476.

- The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

The financial statements have been prepared in accordance with the micro-entity provisions and have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

These financial statements were approved by the board of directors and authorised for issue on 24 September 2021 , and are signed on behalf of the board by:

Mr Stelios Anastasiou Mr Emilios Nicolaou

Director Director

Company registration number: 08800832

The company is a private company limited by shares, registered in England.